Science and entrepreneurship with patients first
We are an international and diverse team of scientists, visionary innovators, and experienced business leaders, dedicated to shaping the future of targeted therapies
Purpose
We exist to bring cures and transform lives for patients in need
Mission
We provide first-in-class delivery platforms, supported by cutting-edge development and manufacturing of cell-mediated therapies
Vision
We strive to unlock the full potential of targeted therapies for every patient in need
The SmartCella Manifesto
At SmartCella, we are driven by passion: we aim to bring cures and transform the lives of patients in need by pioneering new treatment paradigms based on world-class science.
The combination of first-in-class delivery platforms and cutting-edge development and manufacturing of cell-mediated therapies sets us apart. With the Extroducer®, we offer a novel endovascular delivery device that enables injection directly into hard-to-reach organs and tumors. We have capabilities within allogeneic cell therapy development and GMP manufacturing with a focus on heart failure and Parkinson’s disease. And we develop novel mRNA therapies and technologies, with novel modes of delivery.
We are the “go-to” team in delivering the promise of targeted therapies which means bridging the gap from bench to bedside, having the commercial product in mind from the start. We are international scientists, visionary innovators, and experienced business leaders all dedicated to making a profound impact on the future of targeted therapies. Bringing the hope of a longer and healthier life to patients in need is at the center of everything we do.
We thrive when doing what has never been done before – imagining the unimaginable! Our vision is to unlock the full potential of targeted therapies: let the magic behind world-class science transform the lives of patients.
Key milestones
Humble beginnings
ProCella and SmartWise are founded
Development of cardiac cell therapy – ProCella
Research and collaboration agreement established with AstraZeneca
Formation of SmartCella Holding AB
Led by € 20M investment by Fjarde AP-Fonden
Catheter GLP study – SmartWise
Catheter GLP study demonstrates safe and effective drug delivery to abdominal organs in January, 2021
Cardiac progenitor cells POC – ProCella
Large animal POC study delivering cardiac progenitors to the heart completed in collaboration with AstraZeneca in April, 2021
Second investment round – SmartCella
€ 30M investment from AMF, SEB, Celox, and AltoCumulus in September, 2021
Candidate drug nomination – ProCella
Candidate drug nomination of cardiac progenitor cells by AstraZeneca in December, 2021
Catheter receives 510(k) clearance
The first version of the Extroducer receives 510(k) clearance by US FDA
GLP tox study completed – ProCella
GLP tox study for cardiac progenitor cells completed in collaboration with AstraZeneca in June, 2023
GMP manufacturing licensure – ProCella
GMP manufacturing authorization received from Läkemedelsverket, the Swedish Medical Products Agency in December, 2023
50 million EUR raised
Execution of 50m EUR funding with strong new shareholders AstraZeneca, Handelsbanken Fonder, & RoosGruppen
Agreement with XyloCor Therapeutics
First commercial agreement for the Extroducer signed with XyloCor Therapeutics
Delivering on the promise of targeted therapies
A culture that fosters innovation
Transparency
means creating understanding and engagement by communicating in a clear and candid way, being open and honest with each other, feeling comfortable sharing thoughts, concerns, and expressing opinions in a respectful manner.
Creativity
means embracing curiosity about the magic of science and the power of diversity, staying open to new ideas, and committing to lifelong learning. It also means having the courage and persistence to try, fail, and learn from mistakes.
Trust
means taking personal responsibility, acting proactively to honor promises and deadlines, and defined ways of working. It also means showing confidence in the abilities of others, acting with integrity, honesty, and respect, using good judgment and resourcefulness, and treating everyone equally.
Collaboration
means acting inclusively and putting the team first while showing appreciation and acknowledging everyone’s specialist skills and contributions. It also means sharing knowledge, supporting each other and working together to achieve our commons goals. And last but not the least, having fun together!
Leadership team
Meet our management team that brings together with broad experience across development, manufacturing, and commercialization disciplines
Board members
SmartCella in the news
Första patienten behandlad i XyloCor Therapeutics fas IIb-studiemed SmartCellas leveransplattform Extroducer
First patient dosed in XyloCor Therapeutics’ Phase IIb trial using SmartCella’s Extroducer delivery platform
SmartCella forms Scientific Advisory Board with leading global scientific experts
Let’s pioneer the future of targeted therapies together